Third-party regulatory T cells prevent murine acute graft-versus-host disease

BACKGROUND/AIMS: Adoptive therapy with regulatory T (Treg) cells to prevent graft-versus-host disease (GVHD) would benefit from a strategy to improve homing to the sites of inflammation following hematopoietic stem cell transplantation (HSCT). Although donor-derived Treg cells have mainly been used...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Korean J Intern Med
Glavni autori: Lim, Jung-Yeon, Im, Keon-Il, Song, Yunejin, Kim, Nayoun, Nam, Young-Sun, Jeon, Young-Woo, Cho, Seok-Goo
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association of Internal Medicine 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6129628/
https://ncbi.nlm.nih.gov/pubmed/29050459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.319
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items